6 Results for "

rodent anxiety models

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "rodent anxiety models" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-100834
CAS No.: 131123-76-7
Purity:  99.98%
Synonyms: 5,7-DCKA
Target:  

iGluR

Research Areas:  

Neurological Disease

5,7-Dichlorokynurenic acid (5,7-DCKA) is a selective and competitive antagonist of the glycine site on NMDA receptor with a KB of 65 nM. 5,7-Dichlorokynurenic acid reduces NMDA-induced neuron injury. 5,7-Dichlorokynurenic acid increases social interaction time, increases open arm exploration time, disinhibits suppressed conflict responding in rodent models. 5,7-Dichlorokynurenic acid exhibits anxiolytic-like activity in rodent models and supports exploration of glycine’s role in NMDA receptor-mediated synaptic transmission .
loading...
    loading...
Cat. No.: HY-172236
CAS No.: 1020634-41-6
Synonyms: BNC210; IW-2143
Target:  

nAChR

Research Areas:  

Neurological Disease

Soclenicant (BNC210) is an orally active α7 nAChR negative alteration modulator (NAM) with no apparent side effects. Soclenicant exhibits acute anxiolytic activity in rodent models of anxiety. Soclenicant inhibits rat and human α7 nAChR currents (in stably transfected cell lines) induced by acetylcholine, nicotine, choline, and the a7-specific agonist PNU-282987 (HY-12560A) with IC50 values in the range of 1.2 to 3 μM. Soclenicant can be used in studies of anxiety, trauma, and stressor-related disorders .
loading...
    loading...
Cat. No.: HY-103571
CAS No.: 327056-22-4
Target:  

mGluR

Research Areas:  

Neurological Disease

VU0285683 is a selective mGluR5 positive allosteric modulator (PAM). VU0285683 has anxiolytic-like activity in rodent models for anxiety .
loading...
    loading...
Cat. No.: HY-138693
CAS No.: 1186236-75-8
Target:  

FAAH

Research Areas:  

Neurological Disease

ST4070 is a potent, orally active, and selective reversible fatty acid amide hydrolase (FAAH) inhibitor. ST4070 increases endocannabinoid (eCB) brain levels and counteracts neuropathic pain in animal models. ST4070 enhances the endogenous eCB tone in specific brain regions engaged in emotional control, and induces remarkable anxiolytic-like behaviours in rodents. ST4070 can be used for neuropathic pain and anxiety disorders research .
loading...
    loading...
Cat. No.: HY-100834A
CAS No.: 1184986-70-6
Synonyms: 5,7-DCKA sodium
Target:  

iGluR

Research Areas:  

Neurological Disease

5,7-Dichlorokynurenic acid (5,7-DCKA) sodium is a selective and competitive antagonist of the glycine site on NMDA receptor with a KB of 65 nM. 5,7-Dichlorokynurenic acid sodium reduces NMDA-induced neuron injury. 5,7-Dichlorokynurenic acid sodium increases social interaction time, increases open arm exploration time, disinhibits suppressed conflict responding in rodent models. 5,7-Dichlorokynurenic acid sodium exhibits anxiolytic-like activity in rodent models and supports exploration of glycine’s role in NMDA receptor-mediated synaptic transmission .
loading...
    loading...
Cat. No.: HY-131286
CAS No.: 441765-98-6
Synonyms: LY-544344
Target:  

mGluR

Research Areas:  

Neurological Disease

Talaglumetad (LY-544344) is an orally active prodrug of Eglumegad (HY-18941) and a metabotropic glutamate receptor 2/3 (mGluR2/3) agonist. Talaglumetad undergoes transmembrane transport via the intestinal peptide transporter hPepT1, and is enzymatically hydrolyzed to produce L-alanine and the parent drug Eglumegad after entering the body. Talaglumetad can be used in research related to metabotropic glutamate receptor 2-associated neurological systems .
loading...
    loading...